Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP1215818.RAb1qhc9-IHtsQarn3u0ug5cX33Gb99KuxDLSiue6ZUQI130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215818.RAb1qhc9-IHtsQarn3u0ug5cX33Gb99KuxDLSiue6ZUQI130_provenance.
• NP1215821.RAQ8C3F4V7tAfEWQPqkB1c7cmrNf__hwds0Q8vL5jbPd8130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215821.RAQ8C3F4V7tAfEWQPqkB1c7cmrNf__hwds0Q8vL5jbPd8130_provenance.
• NP1215825.RAT7p0sXPquTRCxRjd2jdpa5Ul3a-xXzHtAVFg6yqxfvc130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215825.RAT7p0sXPquTRCxRjd2jdpa5Ul3a-xXzHtAVFg6yqxfvc130_provenance.
• NP1215812.RACpXcDvMJbEiee-sF1KFA9l8WCbN0aR9eVqW5b1CVATE130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215812.RACpXcDvMJbEiee-sF1KFA9l8WCbN0aR9eVqW5b1CVATE130_provenance.
• NP1215814.RABdoU_PCjafd_q3mx6M0BbAEvggafzJhoR7g29dFLrRs130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215814.RABdoU_PCjafd_q3mx6M0BbAEvggafzJhoR7g29dFLrRs130_provenance.
• NP1215826.RABvLI9pT7DsLRE7l5b7bkx6D3aIfUDz2MhDmEJe213Sw130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215826.RABvLI9pT7DsLRE7l5b7bkx6D3aIfUDz2MhDmEJe213Sw130_provenance.
• NP1215811.RAhguQejGGX1X8uOCUEGlHJ294ZG4dRSZD9ul2P4PXnIg130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215811.RAhguQejGGX1X8uOCUEGlHJ294ZG4dRSZD9ul2P4PXnIg130_provenance.
• NP1215813.RAi2R3PrlbZIwcgUGCFsXVhyF5tJt9eZTPkd6FKqIKjjc130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215813.RAi2R3PrlbZIwcgUGCFsXVhyF5tJt9eZTPkd6FKqIKjjc130_provenance.
• NP1215815.RAo9Ur5zcLIygy-PkAO07atTIQ2KWYMzb4N0EAmE_ve8M130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215815.RAo9Ur5zcLIygy-PkAO07atTIQ2KWYMzb4N0EAmE_ve8M130_provenance.
• NP1215817.RAmshH64exThcbVi-nzrt5GzERLWnZNQBkeSpgfLWT4BY130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215817.RAmshH64exThcbVi-nzrt5GzERLWnZNQBkeSpgfLWT4BY130_provenance.
• NP1215822.RAhyLShyo78ttETUe1xRDwqMSv00qn_yefp8hNSpAk0mY130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215822.RAhyLShyo78ttETUe1xRDwqMSv00qn_yefp8hNSpAk0mY130_provenance.
• NP1215823.RAmfQmzcoBGN8Bgd7iFJhhlmWYvfvT67KCep7oCrmxfdc130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215823.RAmfQmzcoBGN8Bgd7iFJhhlmWYvfvT67KCep7oCrmxfdc130_provenance.
• NP1215824.RAp-otZ6yIpQkbZqFdx-Zrleay1b74O7WURsLQebMWb_Q130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215824.RAp-otZ6yIpQkbZqFdx-Zrleay1b74O7WURsLQebMWb_Q130_provenance.
• NP1215827.RAMUIDNHDuWgUVZc1iwzjEV7PT8gthfyD3l2oK70DMyGQ130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215827.RAMUIDNHDuWgUVZc1iwzjEV7PT8gthfyD3l2oK70DMyGQ130_provenance.
• NP1215810.RA_UpgWd3U0UveP-GQMPGpULm5-QN315lwWcu76DFzlBc130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215810.RA_UpgWd3U0UveP-GQMPGpULm5-QN315lwWcu76DFzlBc130_provenance.
• NP1215816.RA_j5BYwoRfCh5iCaFFLrMf1w378k2A4jTvsJnE0Tug24130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215816.RA_j5BYwoRfCh5iCaFFLrMf1w378k2A4jTvsJnE0Tug24130_provenance.
• NP1215819.RA9nFDbme4aK_1LBDbW_zouC3Uya8JbgjVz3vXEtQQa54130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215819.RA9nFDbme4aK_1LBDbW_zouC3Uya8JbgjVz3vXEtQQa54130_provenance.
• NP1215820.RA2qHwGMrJU60KsIcWOwK9bFKeu1kpGgCSeGq7H2deYiM130_assertion description "[MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215820.RA2qHwGMrJU60KsIcWOwK9bFKeu1kpGgCSeGq7H2deYiM130_provenance.